Captrust Financial Advisors Tenaya Therapeutics, Inc. Transaction History
Captrust Financial Advisors
- $38.8 Billion
- Q1 2025
A detailed history of Captrust Financial Advisors transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 14,481 shares of TNYA stock, worth $8,688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,481Holding current value
$8,688% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TNYA
# of Institutions
106Shares Held
48.6MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$5.64 Million12.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$4.04 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$3.55 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$2.45 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$2.44 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $24.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...